MA46539A - Structures et mécanisme pour la conception de glucocorticoïdes hautement puissants - Google Patents

Structures et mécanisme pour la conception de glucocorticoïdes hautement puissants

Info

Publication number
MA46539A
MA46539A MA046539A MA46539A MA46539A MA 46539 A MA46539 A MA 46539A MA 046539 A MA046539 A MA 046539A MA 46539 A MA46539 A MA 46539A MA 46539 A MA46539 A MA 46539A
Authority
MA
Morocco
Prior art keywords
glucocorticoids
structures
design
highly powerful
powerful
Prior art date
Application number
MA046539A
Other languages
English (en)
Inventor
Yuanzheng He
Huaqiang Eric Xu
Original Assignee
Van Andel Res Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Van Andel Res Institute filed Critical Van Andel Res Institute
Publication of MA46539A publication Critical patent/MA46539A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only
    • C07J71/0047Nitrogen only at position 2(3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA046539A 2016-10-14 2017-10-13 Structures et mécanisme pour la conception de glucocorticoïdes hautement puissants MA46539A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662408314P 2016-10-14 2016-10-14

Publications (1)

Publication Number Publication Date
MA46539A true MA46539A (fr) 2019-08-21

Family

ID=61906432

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046539A MA46539A (fr) 2016-10-14 2017-10-13 Structures et mécanisme pour la conception de glucocorticoïdes hautement puissants

Country Status (12)

Country Link
US (1) US10954265B2 (fr)
EP (1) EP3525870B1 (fr)
JP (2) JP7146750B2 (fr)
KR (1) KR102497070B1 (fr)
CN (1) CN110382033B (fr)
ES (1) ES2945983T3 (fr)
MA (1) MA46539A (fr)
PH (1) PH12019500801A1 (fr)
RU (1) RU2019111101A (fr)
SG (1) SG11201903209TA (fr)
WO (1) WO2018071736A1 (fr)
ZA (1) ZA201902595B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025119398A1 (fr) * 2023-12-08 2025-06-12 浙江柏拉阿图医药科技有限公司 Polymorphe de glucocorticoïde à efficacité élevée, son procédé de préparation et son utilisation
WO2025157225A1 (fr) * 2024-01-24 2025-07-31 浙江柏拉阿图医药科技有限公司 Composé glucocorticoïde à haute efficacité, sa préparation et son utilisation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK66202C (da) 1945-03-03 1948-01-12 Danske Securitas As Kodekontakt til elektriske Alarmanlæg.
DK71662C (da) 1946-09-05 1950-11-06 Ingenioer Frank Broadbent Tørrecentrifuge.
US4049813A (en) 1976-07-15 1977-09-20 Sandoz, Inc. Substituted isoxazolo pyridinones
US5837698A (en) * 1996-05-02 1998-11-17 G. D. Searle & Co. Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
CA2451057A1 (fr) 2001-06-14 2002-12-27 Banyu Pharmaceutical Co., Ltd. Nouveaux derives d'isoxazolopyridone et leur utilisation
GB0119911D0 (en) 2001-08-15 2001-10-10 Novartis Ag Organic Compounds
WO2005048927A2 (fr) * 2003-11-13 2005-06-02 Combinatorx, Incorporated Procedes et reactifs pour le traitement de troubles inflammatoires
EP1940863B1 (fr) * 2005-09-02 2012-09-05 Nicox S.A. Nitro-oxyderives de steroides de glucocorticoides
CN1813768A (zh) * 2005-11-18 2006-08-09 成都力思特制药股份有限公司 治疗呼吸系统疾病的药用组合物及其在制药中的应用
NZ584160A (en) 2007-10-04 2011-05-27 Astrazeneca Ab Steroidal [3,2-c] pyrazole compounds, with glucocorticoid activity
CN101945885A (zh) * 2007-12-20 2011-01-12 阿斯利康(瑞典)有限公司 用作糖皮质激素受体激动剂的甾类衍生物
CA2749585A1 (fr) 2009-01-13 2010-07-22 Van Andel Research Institute Methodes d'utilisation de pyridinones isoxazolo-substituees en tant que glucocorticoides
UY32523A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32520A (es) 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
UY32525A (es) 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
JP2012530140A (ja) * 2009-06-16 2012-11-29 メルク・シャープ・アンド・ドーム・コーポレーション グルココルチコイド受容体アゴニストとしての新規[3,2−c]ヘテロアリールステロイド、組成物およびこの使用
JP2016531852A (ja) * 2013-09-25 2016-10-13 ヴァン アンデル リサーチ インスティテュート 非常に強力なグルココルチコイド
TWI695831B (zh) * 2014-09-13 2020-06-11 香港商南北兄弟藥業投資有限公司 Crth2拮抗劑化合物及其用途

Also Published As

Publication number Publication date
JP2022132464A (ja) 2022-09-08
RU2019111101A3 (fr) 2020-11-27
JP7146750B2 (ja) 2022-10-04
US10954265B2 (en) 2021-03-23
KR102497070B1 (ko) 2023-02-06
EP3525870A4 (fr) 2020-04-29
WO2018071736A9 (fr) 2019-05-23
EP3525870A1 (fr) 2019-08-21
CN110382033A (zh) 2019-10-25
WO2018071736A1 (fr) 2018-04-19
ZA201902595B (en) 2021-04-28
SG11201903209TA (en) 2019-05-30
KR20190068577A (ko) 2019-06-18
CN110382033B (zh) 2022-04-15
PH12019500801A1 (en) 2019-11-11
RU2019111101A (ru) 2020-11-16
EP3525870B1 (fr) 2023-05-10
US20190263853A1 (en) 2019-08-29
ES2945983T3 (es) 2023-07-11
JP2019532071A (ja) 2019-11-07

Similar Documents

Publication Publication Date Title
EP3408858A4 (fr) Structures de graphène pour supercondensateurs
EP3364904A4 (fr) Balayage variable pour dispositifs d'entrée
EP3718819A4 (fr) Mécanisme de retournement
EP3468536A4 (fr) Colloïdosomes à nano-architecture pour libération régulée et déclenchée
EP3630078A4 (fr) Agents pour chimio-embolisation
PT3368534T (pt) Ditosilato de valbenazina e polimorfos do mesmo
SG11202008388TA (en) Movement assistance device
IL264143B (en) Processes for preparing olaparib
HUE055263T2 (hu) 11-Szubsztituált 24-hidroxiszterolok NMDA-hoz kapcsolódó állapotok kezelésére
SG10201701420WA (en) Inspection of Structures
EP3403775A4 (fr) Dispositif d'assistance
EP3721849A4 (fr) Dispositif d'aide
EP3519028A4 (fr) Étrier pour harnais
HUE054542T2 (hu) Glükokortikoid receptor inhibitor
EP3434358A4 (fr) Mélangeur de liquéfaction
EP3722105C0 (fr) Dispositif de roulette s'adaptant à une marche
EP3492614A4 (fr) Acier pour structures mécaniques
IL259391B (en) Hydroxamate triterpenoid derivatives
DK3569211T3 (da) Assistanceindretning
EP3405864A4 (fr) Mystification cpuid pour rétrocompatibilité
EP3412054A4 (fr) Technique de reconfiguration basée sur une priorité pour des unités à distance
PT3411535T (pt) Dispositivo de chuveiro
FR3055892B1 (fr) Materiau silicate de structure olivine
DK3495571T3 (da) Bruseanordning
MA46539A (fr) Structures et mécanisme pour la conception de glucocorticoïdes hautement puissants